Member Info for Latino

In that case they could be working in cohort, so both must go or get kicked out!

Also it begs the question, why the Chairman not stepping in here if CEO is poorly performing….he must step in here.

Abysmal absolutely shocking that CEO has failed to update the market now over 4 months…..begs the question what is he still doing here. Must go or be sacked ASAP!

Big spread, but live quote slightly better buy at 2.65ish..

Have to pay extreme premium now to get back in..if you’ve sold!

They still have loads more to sell over 20%…this is the worrying part.

Rise started at US market opening, so deff something leak from over the pond?

Looks like about to launch??

Hasiba’s rocket is impressive, only problem it’s too straight!

Can’t get any live quotes anymore for 15min now?

Looks like breaking thru resistance..

Missed this last RNS on 29th Dec, it looks like Mr Budd has been warned and is on last legs…about time!

RNS Extract “Although all the resolutions were passed, the Board of genedrive notes that more than 20% of votes were cast against the reappointment of certain directors and the resolution to generally disapply pre-emption rights (subject to certain limits). While the Board believes that all these directors bring considerable experience and expertise to the Board, it intends to engage with shareholders to better understand their concerns on the resolutions.”

Flushed traders, and hopefully start motoring north now..gla

Gaining momentum..some leak?

Many parties in, so expect fireworks and potential bidding war?

NNN may well be selling masks again?

Shorters need to close and quickly as this is heading north, big re-rate coming…!

Absolutely survival and big re-rate on the cards. Company was priced to fail so SP got a lot of catching up to do!

Someone also bought 5m at same price 34.5 so expect RNS on this also shortly.

Manchester, UK - 23 December 2022: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that it was notified on 23 December 2022 that Barry Hextall, Chief Financial Officer of the Company, purchased 3,400,000 ordinary shares of 0.1p each in the Company ("Ordinary Shares") on 23 December 2022 at a price of 0.344p per share in his SIPP account. Following the purchase, Barry Hextall is interested in 4,000,000 Ordinary Shares, representing approximately 0.5 per cent. of the Company's issued share capital.